Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
The development of resistance to trastuzumab in HER2-positive gastroesophageal cancer remains a problem. The use of dual HER2 blockade to overcome this is a therapeutic strategy that should be researched more extensively.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
Wiley
2021
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/34953/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|